ENMC APPROVED 5 WORKSHOP APPLICATIONS

ENMC is happy to announce that 5 workshop applications have been approved in the 2026 Spring review round. These workshops have been planned in January – April 2027.

More details: Workshops 2026-2027

 

 

 

Two new Company Forum members in 2026: argenx and Avidity Biosciences.

We’re excited to share that new companies are joining the ENMC Company Forum in 2026!

A warm welcome to argenx and Avidity Biosciences, Inc., who will be joining our valued partners: Amicus Therapeutics International, Dyne Therapeutics, Lupin Pharmaceuticals, Novartis, Roche, Sanofi, Santhera Pharmaceuticals, and Sarepta Therapeutics.

We are deeply grateful for the continued and growing support of all our partners in advancing our shared mission: connecting people in the neuromuscular field.

Together, we strengthen collaboration, accelerate knowledge exchange, and drive progress for the neuromuscular community.

FSHD Europe – new ENMC Associated Partner

We are thrilled to announce that FSHD Europe has joined as an Associated Partner of the ENMC in 2026, alongside the Österreichische Muskelforschung, SMA Europe, TREAT-NMD, the World Duchenne Organization, and the World Muscle Society. We are grateful for their support in advancing our mission of ‘Connecting People’ within the Neuromuscular field!